These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 15330445

  • 1. Are oxidized LDL/beta2-glycoprotein I complexes pathogenic antigens in autoimmune-mediated atherosclerosis?
    Matsuura E, Lopez LR.
    Clin Dev Immunol; 2004 Jun; 11(2):103-11. PubMed ID: 15330445
    [Abstract] [Full Text] [Related]

  • 2. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR, Simpson DF, Hurley BL, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [Abstract] [Full Text] [Related]

  • 3. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
    Kobayashi K, Lopez LR, Shoenfeld Y, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
    [Abstract] [Full Text] [Related]

  • 4. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis.
    Matsuura E, Kobayashi K, Inoue K, Lopez LR, Shoenfeld Y.
    Lupus; 2005 Jun; 14(9):736-41. PubMed ID: 16218478
    [Abstract] [Full Text] [Related]

  • 5. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
    Matsuura E, Kobayashi K, Tabuchi M, Lopez LR.
    Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
    [Abstract] [Full Text] [Related]

  • 6. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Matsuura E, Kobayashi K, Hurley BL, Lopez LR.
    Lupus; 2006 Nov; 15(7):478-83. PubMed ID: 16898186
    [Abstract] [Full Text] [Related]

  • 7. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis.
    Lopez LR, Salazar-Paramo M, Palafox-Sanchez C, Hurley BL, Matsuura E, Garcia-De La Torre I.
    Lupus; 2006 Nov; 15(2):80-6. PubMed ID: 16539278
    [Abstract] [Full Text] [Related]

  • 8. Immunogenic oxidized low-density lipoprotein/beta2-glycoprotein I complexes in the diagnostic management of atherosclerosis.
    Lopez LR, Kobayashi K, Matsunami Y, Matsuura E.
    Clin Rev Allergy Immunol; 2009 Aug; 37(1):12-9. PubMed ID: 18982458
    [Abstract] [Full Text] [Related]

  • 9. Atherogenic antiphospholipid antibodies in antiphospholipid syndrome.
    Kobayashi K, Lopez LR, Matsuura E.
    Ann N Y Acad Sci; 2007 Jun; 1108():489-96. PubMed ID: 17894014
    [Abstract] [Full Text] [Related]

  • 10. IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome.
    Lopez D, Kobayashi K, Merrill JT, Matsuura E, Lopez LR.
    Clin Dev Immunol; 2003 Jun; 10(2-4):203-11. PubMed ID: 14768953
    [Abstract] [Full Text] [Related]

  • 11. Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen.
    Kobayashi K, Kishi M, Atsumi T, Bertolaccini ML, Makino H, Sakairi N, Yamamoto I, Yasuda T, Khamashta MA, Hughes GR, Koike T, Voelker DR, Matsuura E.
    J Lipid Res; 2003 Apr; 44(4):716-26. PubMed ID: 12562869
    [Abstract] [Full Text] [Related]

  • 12. Atherogenic autoantigen: oxidized LDL complexes with beta2-glycoprotein I.
    Matsuura E, Kobayashia K, Koikeb T, Shoenfeld Y, Khamashta MA, Hughes GR.
    Immunobiology; 2003 Apr; 207(1):17-22. PubMed ID: 12638898
    [Abstract] [Full Text] [Related]

  • 13. Autoimmune-mediated atherothrombosis.
    Matsuura E, Lopez LR.
    Lupus; 2008 Oct; 17(10):878-87. PubMed ID: 18827052
    [Abstract] [Full Text] [Related]

  • 14. [OxLDL/β2-glycoprotein I complex as a pro-atherogenic autoantigen. Is atherosclerosis an autoimmune disease?].
    Kraml P.
    Vnitr Lek; 2016 Oct; 62(11 Suppl 4):S48-51. PubMed ID: 27921425
    [Abstract] [Full Text] [Related]

  • 15. Determination of oxidized low-density lipoproteins (ox-LDL) versus ox-LDL/beta2GPI complexes for the assessment of autoimmune-mediated atherosclerosis.
    Lopez LR, Buckner TR, Hurley BL, Kobayashi K, Matsuura E.
    Ann N Y Acad Sci; 2007 Aug; 1109():303-10. PubMed ID: 17785319
    [Abstract] [Full Text] [Related]

  • 16. Atherosclerosis in autoimmune diseases.
    Matsuura E, Kobayashi K, Lopez LR.
    Curr Rheumatol Rep; 2009 Feb; 11(1):61-9. PubMed ID: 19171113
    [Abstract] [Full Text] [Related]

  • 17. Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases.
    Jara LJ, Medina G, Vera-Lastra O, Amigo MC.
    Autoimmun Rev; 2006 Mar; 5(3):195-201. PubMed ID: 16483919
    [Abstract] [Full Text] [Related]

  • 18. β2-glycoprotein I and oxidative inflammation in early atherogenesis: a progression from innate to adaptive immunity?
    Matsuura E, Lopez LR, Shoenfeld Y, Ames PR.
    Autoimmun Rev; 2012 Dec; 12(2):241-9. PubMed ID: 22569463
    [Abstract] [Full Text] [Related]

  • 19. Autoantibody-mediated atherosclerosis.
    Matsuura E, Kobayashi K, Koike T, Shoenfeld Y.
    Autoimmun Rev; 2002 Dec; 1(6):348-53. PubMed ID: 12848990
    [Abstract] [Full Text] [Related]

  • 20. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Lopez D, Garcia-Valladares I, Palafox-Sanchez CA, De La Torre IG, Kobayashi K, Matsuura E, Lopez LR.
    Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.